Intratracheal administration of umbilical cord blood-derived mesenchymal stem cells in a patient with acute respiratory distress syndrome

Journal of Korean Medical Science

Volumn 29, Issue 3, 2014, Pages 438-440

  Chang, Youjin ^a   Park, So Hee ^a   Huh, Jin Won ^a   Lim, Chae Man ^a   Koh, Younsuck ^a   Hong, Sang Bum ^a  

^a University of Ulsan College of Medicine   (South Korea)

Author keywords

Acute lung injury; Acute respiratory distress syndrome; Stem cells; Therapy

Indexed keywords

ACUTE LUNG INJURY; ADULT RESPIRATORY DISTRESS SYNDROME; ARTICLE; BACTERIAL INFECTION; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; CYTOLOGY; FETUS BLOOD; HUMAN; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMA CELL; MIDDLE AGED; MULTIDRUG RESISTANCE; RADIOGRAPHY; SEIZURE; SEPTIC SHOCK; STEM CELL; THERAPY; TREATMENT OUTCOME;

ACUTE LUNG INJURY; ACUTE RESPIRATORY DISTRESS SYNDROME; STEM CELLS; THERAPY;

BACTERIAL INFECTIONS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; FETAL BLOOD; HUMANS; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; MIDDLE AGED; RESPIRATORY DISTRESS SYNDROME, ADULT; SEIZURES; SHOCK, SEPTIC; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 84908365579     PISSN: 10118934     EISSN: 15986357     Source Type: Journal    
DOI: 10.3346/jkms.2014.29.3.438     Document Type: Article

References (5)

1. Loebinger MR, Janes SM. Stem cells for lung disease. Chest 2007; 132: 279-85.
2. Lee JW, Fang X, Krasnodembskaya A, Howard JP, Matthay MA. Concise review: mesenchymal stem cells for acute lung injury: role of paracrine soluble factors. Stem Cells 2011; 29: 913-9.
3. Matthay MA, Goolaerts A, Howard JP, Lee JW. Mesenchymal stem cells for acute lung injury: preclinical evidence. Crit Care Med 2010; 38(10 Suppl): S569-73.
4. Mac Sweeney R, McAuley DF. Mesenchymal stem cell therapy in acute lung injury: is it time for a clinical trial? Thorax 2012; 67: 475-6.
5. Le Blanc K, Frassoni F, Ball L, Locatelli F, Roelofs H, Lewis I, Lanino E, Sundberg B, Bernardo ME, Remberger M, et al. Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study. Lancet 2008; 371: 1579-86.